NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

MOUNTAIN VIEW, California., Aug 11, 2022 (GLOBE NEWSLETTER) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people with epilepsy, today announced that the company has entered into a commercialization agreement with DIXI Medical® United States (“DIX”). NeuroPace will be the exclusive U.S distributor of DIXI’s product line … Read more